Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Oktober 2024

Biotek-snakken — Oktober 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
76 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • F Offline
    F Offline
    Fandel
    wrote on sidst redigeret af
    #65

    Godmorgen...

    1 Reply Last reply
    0
    • P Offline
      P Offline
      ProinvestorNEWS
      wrote on sidst redigeret af
      #66

      AbbVie adds anti-amyloid asset to its CNS repertoire in $1.4B-buyout of Aliada https://firstwordpharma.com/story/5907150

      1 Reply Last reply
      0
      • L Offline
        L Offline
        LP90
        wrote on sidst redigeret af
        #67

        Godmorgen 🙂

        1 Reply Last reply
        0
        • F Offline
          F Offline
          Fandel
          wrote on sidst redigeret af
          #68

          Første patient indrulleret - BioPorto har påbegyndt indrullering til det amerikanske studie vedrørende ProNephro AKI (NGAL)™ til voksen brug ved Massachusetts General Hospital

          1 Reply Last reply
          0
          • F Offline
            F Offline
            Fandel
            wrote on sidst redigeret af
            #69

            Godmorgen...

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #70

              Biogen And Neomorph Collaborate To Develop Molecular Glue Degraders For Alzheimer's And More https://proinvestor.com/investornyt/1234743/biogen-and-neomorph-collaborate-to-develop-molecular-glue-degraders-for-alzheimers-and-more

              1 Reply Last reply
              0
              • L Offline
                L Offline
                LP90
                wrote on sidst redigeret af
                #71

                Godmorgen 🙂

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #72

                  Zymeworks står overfor sin første mulige godkendelse med PDUFA date den 29 november for zanidatamab. De har 6 investorpræsentationer i den kommende tid, så de retter i den grad fokus på sig selv!

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #73

                    https://ir.zymeworks.com/news-releases/news-release-details/zymeworks-announces-participation-upcoming-investor-19

                    1 Reply Last reply
                    0
                    • exitnuE Offline
                      exitnuE Offline
                      exitnu
                      wrote on sidst redigeret af
                      #74

                      Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants

                      Link Preview Image
                      NIH VideoCast - Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants

                      The Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (collectively, we) are announcing a public workshop entitled “Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants.” The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with use of live biotherapeutic products to prevent necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants.

                      For more information go to https://web.cvent.com/event/7d104839-6b90-4934-aff3-7c273ea4256a/summary

                      favicon

                      NIH VideoCast (videocast.nih.gov)

                      IBT på FDA-workshoppen i USA ..

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #75

                        Lundbeck fremlægger positive fase 3-resultater med migrænemiddel https://proinvestor.com/investornyt/1235691/lundbeck-fremlaegger-positive-fase-3-resultater-med-migraenemiddel

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          lahn1
                          wrote on sidst redigeret af
                          #76

                          Sukkeralf- regnes den godkendelse ikke værende lige så sikker som amen i kirken? Hvornår er det der ventes nyt vedr GEA ?

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #77

                            Det tænker jeg men man ved jo aldrig. GEA udsat til Q2 2025

                            1 Reply Last reply
                            0

                            Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                            Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                            With your input, this post could be even better 💗

                            Tilmeld Log ind
                            Svar
                            • Svar som emne
                            Login for at svare
                            • Ældste til nyeste
                            • Nyeste til ældste
                            • Most Votes


                            • Log ind

                            • Har du ikke en konto? Tilmeld

                            • Login or register to search.
                            Powered by NodeBB Contributors
                            • First post
                              Last post
                            0
                            • Kategorier
                            • Seneste
                            • Etiketter
                            • Populære
                            • Verden
                            • Bruger
                            • Grupper